These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37887282)

  • 1. Runx3 Restoration Regresses K-Ras-Activated Mouse Lung Cancers and Inhibits Recurrence.
    Lee JY; Lee JW; Park TG; Han SH; Yoo SY; Jung KM; Kim DM; Lee OJ; Kim D; Chi XZ; Kim EG; Lee YS; Bae SC
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887282
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Lee YS; Lee JY; Song SH; Kim DM; Lee JW; Chi XZ; Ito Y; Bae SC
    Mol Cells; 2020 Oct; 43(10):889-897. PubMed ID: 33115981
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of RUNX3 in Restriction Point Regulation.
    Lee JW; Lee YS; Kim MK; Chi XZ; Kim D; Bae SC
    Cells; 2023 Feb; 12(5):. PubMed ID: 36899846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma.
    Lee YS; Lee JW; Jang JW; Chi XZ; Kim JH; Li YH; Kim MK; Kim DM; Choi BS; Kim EG; Chung JH; Lee OJ; Lee YM; Suh JW; Chuang LS; Ito Y; Bae SC
    Cancer Cell; 2013 Nov; 24(5):603-16. PubMed ID: 24229708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RUNX3 and p53: How Two Tumor Suppressors Cooperate Against Oncogenic Ras?
    Lee JW; van Wijnen A; Bae SC
    Adv Exp Med Biol; 2017; 962():321-332. PubMed ID: 28299666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer.
    Lee KS; Lee YS; Lee JM; Ito K; Cinghu S; Kim JH; Jang JW; Li YH; Goh YM; Chi XZ; Wee H; Lee HW; Hosoya A; Chung JH; Jang JJ; Kundu JK; Surh YJ; Kim WJ; Ito Y; Jung HS; Bae SC
    Oncogene; 2010 Jun; 29(23):3349-61. PubMed ID: 20228843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Runt-related transcription factor RUNX3 is a target of MDM2-mediated ubiquitination.
    Chi XZ; Kim J; Lee YH; Lee JW; Lee KS; Wee H; Kim WJ; Park WY; Oh BC; Stein GS; Ito Y; van Wijnen AJ; Bae SC
    Cancer Res; 2009 Oct; 69(20):8111-9. PubMed ID: 19808967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status.
    Omar MF; Ito K; Nga ME; Soo R; Peh BK; Ismail TM; Thakkar B; Soong R; Ito Y; Salto-Tellez M
    Pathol Oncol Res; 2012 Oct; 18(4):783-92. PubMed ID: 22729835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic downregulation of RUNX3 by DNA methylation induces docetaxel chemoresistance in human lung adenocarcinoma cells by activation of the AKT pathway.
    Zheng Y; Wang R; Song HZ; Pan BZ; Zhang YW; Chen LB
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2369-78. PubMed ID: 23892093
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Ito K; Otani S; Date Y
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low frequency of p53 and k-ras codon 12 mutations in non-small cell lung carcinoma (NSCLC) tumors and surgical margins.
    Vatan O; Bilaloglu R; Tunca B; Cecener G; Gebitekin C; Egeli U; Yakut T; Urer N
    Tumori; 2007; 93(5):473-7. PubMed ID: 18038880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do K-RAS-activated cells evade cellular defense mechanisms?
    Lee YS; Bae SC
    Oncogene; 2016 Feb; 35(7):827-32. PubMed ID: 25961920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RUNX3 modulates DNA damage-mediated phosphorylation of tumor suppressor p53 at Ser-15 and acts as a co-activator for p53.
    Yamada C; Ozaki T; Ando K; Suenaga Y; Inoue K; Ito Y; Okoshi R; Kageyama H; Kimura H; Miyazaki M; Nakagawara A
    J Biol Chem; 2010 May; 285(22):16693-703. PubMed ID: 20353948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalein increases the expression and reciprocal interplay of RUNX3 and FOXO3a through crosstalk of AMPKα and MEK/ERK1/2 signaling pathways in human non-small cell lung cancer cells.
    Zheng F; Wu J; Zhao S; Luo Q; Tang Q; Yang L; Li L; Wu W; Hann SS
    J Exp Clin Cancer Res; 2015 May; 34(1):41. PubMed ID: 25948105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from B6C3F1 mice exposed to cumene.
    Hong HH; Ton TV; Kim Y; Wakamatsu N; Clayton NP; Chan PC; Sills RC; Lahousse SA
    Toxicol Pathol; 2008 Jul; 36(5):720-6. PubMed ID: 18648094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Runx3 plays a critical role in restriction-point and defense against cellular transformation.
    Chi XZ; Lee JW; Lee YS; Park IY; Ito Y; Bae SC
    Oncogene; 2017 Dec; 36(50):6884-6894. PubMed ID: 28846108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.
    Fisher GH; Wellen SL; Klimstra D; Lenczowski JM; Tichelaar JW; Lizak MJ; Whitsett JA; Koretsky A; Varmus HE
    Genes Dev; 2001 Dec; 15(24):3249-62. PubMed ID: 11751631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas.
    Tran PT; Fan AC; Bendapudi PK; Koh S; Komatsubara K; Chen J; Horng G; Bellovin DI; Giuriato S; Wang CS; Whitsett JA; Felsher DW
    PLoS One; 2008 May; 3(5):e2125. PubMed ID: 18461184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement of the NF-kappaB subunit p65/RelA for K-Ras-induced lung tumorigenesis.
    Bassères DS; Ebbs A; Levantini E; Baldwin AS
    Cancer Res; 2010 May; 70(9):3537-46. PubMed ID: 20406971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of p53 and K-ras in lung carcinomas of coal miners.
    Sarkar FH; Li Y; Vallyathan V
    Int J Mol Med; 2001 Oct; 8(4):453-9. PubMed ID: 11562787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.